Last update :
05/12/2025
References   References 3261  
Type : Manufacturer

Research teams :
Authors :
Title : Belatacept (Nulojix®) – Résumé des caractéristiques du produit
Reference : Bristol Myers Squibb 2011

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionBelatacept Immunosuppressant
Stability in solutions Not specified Sodium chloride 0,9% 2 >> 10 mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Sodium chloride 0,9% 2 >> 10 mg/ml 25°C Not specified
4 Hour
Stability in solutions Not specified Glucose 5% 2 >> 10 mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Glucose 5% 2 >> 10 mg/ml 25°C Not specified
4 Hour
Compatible + Sodium chloride 0,9%
Compatible + Glucose 5%

  Mentions Légales